(Q37952623)

25 August 2017

1 reference

title

Type I interferons (alpha and beta) in HIV disease (English)

1 reference

25 August 2017

Krown SE

1

1 reference

25 August 2017

publication date

1 January 1990

1 reference

Biotherapy (Dordrecht, Netherlands)

25 August 2017

published in

1 reference

25 August 2017

volume

2

1 reference

25 August 2017

issue

2

1 reference

25 August 2017

page(s)

137-147

1 reference

Recombinant Leukocyte A Interferon: Pharmacokinetics, Single-Dose Tolerance, and Biologic Effects in Cancer Patients

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02173453

Synergistic inhibition of human immunodeficiency virus in vitro by azidothymidine and recombinant alpha A interferon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02173453

Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02173453

Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02173453

Elevated levels of interferon-induced 2'-5' oligoadenylate synthetase in generalized persistent lymphadenopathy and the acquired immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02173453

Zidovudine in patients with human immunodeficiency virus (HIV) infection and Kaposi sarcoma. A phase II randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02173453

Circulating p24 antigen levels and responses to dideoxycytidine in human immunodeficiency virus (HIV) infections. A phase I and II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02173453

Human alpha- and beta-interferon but not gamma- suppress the in vitro replication of LAV, HTLV-III, and ARV-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02173453

Synergistic interaction of 2',3'-dideoxycytidine and recombinant interferon-alpha-A on replication of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02173453

21 January 2018

Identifiers

DOI

10.1007/BF02173453

1 reference

25 August 2017

1 reference